Abstract
59
Importantly, no population-scale proteome datasets have been generated from human 60 pluripotent cells.
62
Here, we report on the first comprehensive, population-scale, combined proteomics and gene (Fig. 1C) , consistent with observations in other cell types and organisms 13, 14 .
94
Our data provide the most comprehensive analysis of the human iPSC proteome reported to 95 date, and one of the most comprehensive proteomic datasets reported for any human primary 96 or derived cell type (Supp. 
116
RNA and proteome variability
117
Across iPSC lines, the majority of genes showed low RNA and protein coefficients of variation
118
( Fig. 2A) , with only weak to moderate global correlation across the lines (Fig. 2B) . Notably,
119
many highly variable RNAs showed low covariation with protein (985 RNA-protein pairs with r 120 < 0.2), indicating that the variation in protein abundance between iPSC lines is not explained
121
solely by variation in RNA expression levels.
123
Next, we assessed a range of factors, including the cell line donor, age, sex, as well as culture 124 medium and other technical factors, for their potential contribution to the variation in protein 125 expression between iPSC lines ( Fig. 2C; Methods) . The largest effects on protein variation
126
were associated with donor effects and culture medium (Fig. 2C) (Fig. 2D) .
157
There were differences between modules with high RNA and protein variability (e.g. clusters
158
1, 2, 3), both in the specific enriched GO terms and in their variance components (Fig. 2D,E) .
159
For example, Cluster 2 was enriched for proteins encoded on the X chromosome and variation
160
was associated with the sex of the donor, at both the RNA and protein levels. In contrast,
161
Cluster 4 showed high variability in protein abundance, but low RNA variability (Fig. 2E) . The
162
134 proteins in Cluster 4 were enriched for integral membrane proteins and their variation was 163 linked to the culture medium variance component (Fig. 2E) , which was not explained by biases
164
in the quantification of peptides from membrane proteins (Supp. Fig. 5 ). This indicates that 165 differences in the cellular environment can affect the abundance of Cluster 4 proteins, and is
166
not driven by changes in transcriptional regulation.
168
In summary, analysis across the 202 iPSC lines shows significant donor-to-donor variation in 
201
Globally, eQTL and pQTL effect sizes were moderately correlated (Supp. Fig. 11 ). An
202
example of an eQTL with a corresponding effect at the protein level is the lead eQTL variant 203 rs1129187 for the PEX6 gene (Fig. 3B) 
261
The transcript QTLs also provided insights into why some pQTLs were not detected as eQTLs.
262
Out of 234 pQTLs for which no corresponding eQTL was found, we identified 66 pQTLs with 263 a significant transcript QTL (Supp. 
270
Finally, we used the peptide-level QTL information to explore, at higher resolution, isoform- 
361
set of random control QTL variants (Fig. 6A) . The data show that QTLs affecting both RNA
362
and protein expression levels are more likely to tag a disease variant, compared with either 363 eQTL corresponding to non-protein coding genes, or eQTL that do not result in a detectable 364 protein effect (Fig. 6B) . Notably, these differences could not be explained by differences in 365 the number of eQTL and pQTL discoveries (Supp. Fig. 15 ).
367
Of note, 19 of the pQTLs without a detectable effect at the RNA level tag GWAS variants
368
(Supp . Table 7 ). One such example is the cis pQTL of VRK2, rs1051061 (Supp. Fig. 17 
469
Samples with low quality RNA-seq were discarded, if they had less than 2 billion bases 470 aligned, had less than 30% coding bases, or had a duplication rate higher than 75% were.
471
This resulted in 323 lines for analysis, for 202 of which matched proteome data was available.
473
Gene-level RNA expression was quantified from the STAR alignments using featureCounts
474
(v1.6.0)
37
, which was applied to the primary alignments using the "-B" and "-C" options in 
479
Transcript isoform expression was quantified directly from the (unaligned) trimmed reads 480 using Salmon 22 (version: 0.8.2), using the "--seqBias", "--gcBias" and "VBOpt" options in "ISR"
481
mode to match our inward stranded sequencing reads. 
499
Lys-C (Wako, Japan), then diluted a further 2.5-fold before a second digestion with trypsin.
500
Lys-C and trypsin were used at an enzyme to substrate ratio of 1:50 (w/w). batches. The other nine quantification channels were used to label 9 different cell lines.
515
The TMT samples were fractionated using off-line high pH reverse phase chromatography:
516
samples were loaded onto a 4.6 x 250 mm Xbridge TM BEH130 C18 column with 3.5 µm 517 particles (Waters). Using a Dionex bioRS system, the samples were separated using a 25-518 minute multistep gradient of solvents A (10 mM formate at pH 9) and B (10 mM ammonium 519 formate pH 9 in 80% acetonitrile), at a flow rate of 1 ml/min. Peptides were separated into 48 520 fractions, which were consolidated into 24 fractions. The fractions were subsequently dried 521 and the peptides redissolved in 5% formic acid and analysed by LC-MS.
522
5% of the material was analysed using an orbitrap fusion tribrid mass spectrometer (Thermo
523
Scientific), equipped with a Dionex ultra high-pressure liquid chromatography system (nano 524 RSLC). RP-LC was performed using a Dionex RSLC nano HPLC (Thermo Scientific).
525
Peptides were injected onto a 75 μm × 2 cm PepMap-C18 pre-column and resolved on a 75 
537
During the MS3 analysis for more accurate TMT quantifications, 5 fragment ions were co-538 isolated using synchronous precursor selection using a window of 2 Th and further fragmented 539 using HCD collision energy of 55% 39 The fragments were then analysed in the orbitrap with 540 a resolution of 60,000. The AGC target was set to 1.0 e5 and the maximum injection time was 541 set to 105 ms.
542
Proteomics data processing
543
The TMT labeled samples (24 batches of TMT-ten plex) were analysed using MaxQuant v. 
548
The following search parameters were used: reporter ion quantification, mass deviation of 6 549 ppm on the precursor and 0.5 Da on the fragment ions; Tryp/P for enzyme specificity; up to 550 two missed cleavages, "match between runs", "iBAQ". Carbamidomethylation on cysteine was 551 set as a fixed modification. Oxidation on methionine; pyro-glu conversion of N-terminal Gln,
552
deamidation of asparagine and glutamine and acetylation at the protein N-terminus were set 553 as variable modifications [40] [41] [42] .
554
Peptides and protein groups were identified at a False Discovery Rate (FDR) of 5%. The same
555
FDR was applied to the Post-Translational Modifications (PTM) Site and the Peptide Spectrum 
561
Quality control and quantification
562
To rule out technical confounding when performing genetic analyses of protein traits, we 563 discarded 2,072 peptides that overlap a non-synonymous common variant (MAF>5% in
564
European population) in expressed transcript (average TPM>1 based on RNA-seq). Protein 565 group abundances were then estimated as the sum of peptide intensities mapped to a protein 566 group. For peptide abundance we use the intensities reported in the "Peptides" file from
567
MaxQuant.
568
We discarded 10 lines with fewer than 67,000 identified peptides (corresponding to %75 of 569 the median number of peptides identified; Supp. 
574
In aggregate across all lines, we detected 16,218 protein groups. For downstream analysis,
575
we considered protein groups that were detected in at least 30 of the 202 lines and 576 analogously considered recurrently detected peptides (Supp. Fig. 2 
598
Comparisons of iPS proteome profiles to existing tissue datasets 
688
We defined a lead QTL variant as 'replicating' across molecular layers if it had, for the same 689 gene, a statistically significant effect and the same direction of effect on both layers. For the 690 replicating layer, the statistical significance is defined using the nominal p-value (P<0.01), or 
694
We trained a multivariate logistic regression model to the replication status of 1,887 genes 695 with an eQTL for which the protein and the RNA were identified in all lines (Supp. 
696
This stringent filter on the set of genes was used to mitigate effects due to differences in 697 samples size (pQTLs tests were performed on the set of in which the protein was detected).
698
For each RNA-protein pair, we defined 7 factors. The "protein coefficient of error" factor was 699 computed as the coefficient of variation across the set of technical replicates (i.e. across the replicate measurements of the reference sample that was included in every TMT batch). The 701 "protein complex membership" factor was assessed using existing annotation (CORUM 702 release May 2017; 47 ), which was set to one if the gene encodes for the subunit of a protein 703 complex and zero otherwise. The "only-nc-tQTLs" factor was obtained by assessing the 704 replication of eQTLs for protein coding genes in transcript isoform QTLs (tQTLs), which was 705 set to one if the eQTL was replicated in tQTL corresponding to a non-protein coding transcript 706 isoform coding tQTL (but not in one corresponding to a protein coding isoform). When this 707 assessment was not possible, or when the eQTL was replicated in at least one coding tQTL,
708
we set the factor to 0. 
